外周带前列腺癌的多参数MR成像:穿刺后出血对基于Gleason评分和肿瘤体积的癌症检测的影响
本回顾性研究纳入54例经活检证实的前列腺癌患者,由两名独立阅片者按PI-RADS v2评估外周带各 sextant,并记录T1WI上的出血。结果显示,穿刺后出血对Gleason评分≥3+4或体积≥0.5 ml的临床显著外周带前列腺癌的检测准确度(AUC)无显著影响。
要点
- 穿刺后出血在37.7%的外周带 sextant 中出现,但未显著降低临床显著前列腺癌的检测准确度。
- 出血与无出血 sextant 之间,检测Gleason评分≥3+4或肿瘤体积≥0.5 ml癌症的AUC无显著差异(所有p>0.2)。
- 在外周带前列腺癌的多参数MR评估中,穿刺后出血似乎不影响对临床显著癌的检出。
核心结论
- 穿刺后出血未对多参数MR成像检测临床显著外周带前列腺癌产生负面影响。
研究设计与样本
- 回顾性研究,纳入54例经活检证实的前列腺癌患者(中位年龄67.0岁),行多参数MR成像,两名独立阅片者按PI-RADS v2评估外周带各 sextant,其中一名阅片者记录T1加权MR图像上每个 sextant 有无出血。
关键影像表现/征象
- 穿刺后出血见于全部患者324个 sextant 中的122个(37.7%)。
诊断标准与关键数值
- 出血 sextant 中,阅片者1检测Gleason评分≥3+4的AUC为0.83、检测肿瘤体积≥0.5 ml的AUC为0.84;阅片者2对应AUC分别为0.74和0.77。
- 无出血 sextant 中,阅片者1检测Gleason评分≥3+4的AUC为0.86、检测肿瘤体积≥0.5 ml的AUC为0.88;阅片者2对应AUC分别为0.79和0.83。
- 出血与无出血 sextant 之间上述AUC差异均无统计学意义(所有p>0.2)。
临床应用与阅片要点
- 作者认为,在穿刺后出血影响下,多参数MR可用于检测临床显著外周带前列腺癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate effect of postbiopsy hemorrhage on detection of peripheral zone (PZ) prostate cancer by multiparametric MR imaging according to Gleason score and tumor volume.
METHODS: This retrospective study included 54 biopsy-proven prostate cancer patients (median age, 67.0 years) who underwent multiparametric MR imaging. Two independent readers evaluated each sextant of the PZ using the PI-RADS v2. One reader recorded the presence or absence of hemorrhage per sextant on T1 weighted MR images. Areas under the receiver operating characteristic curves (AUCs) were used to evaluate cancer detection accuracy.
RESULTS: Postbiopsy hemorrhage was noted in 122 (37.7%) of 324 sextants of all patients. There was no significant difference in the AUC for detection of cancer with Gleason score ≥3 + 4 or volume ≥0.5 ml between sextants with and without hemorrhage (with hemorrhage, reader 1, 0.83 for Gleason score ≥3 + 4, 0.84 for tumor volume ≥0.5 ml; reader 2, 0.74 for Gleason score ≥3 + 4, 0.77 for tumor volume ≥0.5 ml; without hemorrhage, reader 1, 0.86 for Gleason score ≥3 + 4, 0.88 for tumor volume ≥0.5 ml; reader 2, 0.79 for Gleason score ≥3 + 4, 0.83 for tumor volume ≥0.5 ml; p > 0.2 for all).
CONCLUSION: Postbiopsy hemorrhage did not negatively affect the detection of clinically significant PZ prostate cancer on multiparametric MR imaging. Advances in knowledge: Under influence of postbiopsy hemorrhage, multiparametric MR can be useful for the detection of clinically significant PZ prostate cancer.
引用
- Jung SI, Jeon HJ, Park HS, et al. Multiparametric MR imaging of peripheral zone prostate cancer: effect of postbiopsy hemorrhage on cancer detection according to Gleason score and tumour volume. Br J Radiol. 2018. PMID: 29493284. doi:10.1259/bjr.20180001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。